Paola Orlandi

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects”.

New antiproliferative agents derived from tricyclic 3,4‐dihydrobenzo[4,5]imidazo[1,2‐a][1,3,5]triazine scaffold: Synthesis and pharmacological effects

Archiv der Pharmazie(2022)10.1002/ardp.202200295

N/A

0DataRank · unranked

5 citations

Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini, Marta Banchi +7 more

New antiproliferative agents derived from tricyclic 3,4-dihydrobenzo[4,5]imidazo[1,2-a][1,3,5]triazine scaffold: synthesis and pharmacological effects

SSRN Electronic Journal(2022)10.2139/ssrn.4115546

N/A

0DataRank · unranked

0 citations

Silvia Salerno, Elisabetta Barresi, Paola Orlandi, Francesca Vaglini, Marta Bianchi +7 more

Melanocortin-4 Receptor Antagonism Inhibits Colorectal and Anaplastic Thyroid Cancer In Vitro and In Vivo

Journal of Clinical Medicine(2025)10.3390/jcm14041165

N/A

0DataRank · unranked

2 citations

Marta Banchi, Paola Orlandi, Francesca Vaglini, Greta Alì, Gabriella Fontanini +8 more